LncRNA‐UCA1 modulates progression of colon cancer through regulating the miR‐28‐5p/HOXB3 axis

Emerging evidence has shown that the long noncoding RNA urothelial carcinoma–associated 1 (UCA1) plays a tumor‐promoting role in colorectal cancer, while miR‐28‐5p shows tumor‐inhibitory activity in several tumor types. However, the mechanisms both of these in colon cancer progression are still unknown. In this work, the detailed roles and mechanisms of UCA1 and its target genes in colon cancer were studied. The results showed that UCA1 was upregulated in colon cancer tissues when compared with the adjacent nonhumorous tissues, as well as in the various colon cancer cell lines, but the expression of miR‐28‐5p showed an opposite trend. Furthermore, a high UCA1 level in colon cancer tissues is positively associated with the tumor size and advanced tumor stages. Functional assays revealed that both UCA1 knockdown and miR‐28‐5p overexpression could inhibit colon cancer cell growth and migration. Further mechanistic studies indicated that UCA1 knockdown played tumor suppressive roles in SW480 and HT116 cells through binding with miR‐28‐5p. We also, for the first time, identified HOXB3 as the target gene of miR‐28‐5p and that HOXB3 overexpression could mediate the functions of UCA1 in cell proliferation and migration of colon cancer cells. In conclusion, our data provided evidence for the regulatory network of UCA1/miR‐28‐5p/HOXB3 in colon cancer, suggesting that UCA1, miR‐28‐5p, and HOXB3 are the potential targets for colon cancer therapy. 1.Our data provided evidence for the regulatory network of urothelial carcinoma–associated 1 (UCA1)/miR‐28‐5p/HOXB3 in colon cancer. 2. Our data suggested that UCA1, miR‐28‐5p, and HOXB3 are the potential targets for colon cancer therapy.